365.81
2.87%
-10.79
Argen X SE ADR (ARGX) 最新ニュース
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday - MSN
MSN
Breaking Down argenx: 12 Analysts Share Their Views
Benzinga
Earnings call: Argenx reports robust Q1 growth with VYVGART expansion - Investing.com India
Investing.com India
Earnings call: Argenx reports robust Q1 growth with VYVGART expansion - Investing.com
Investing.com
Examining Argen X SE ADR (ARGX) stock is warranted – US Post News - US Post News
US Post News
argenx shares target cut, maintains buy By Investing.com - Investing.com
Investing.com
Earnings call: Argenx reports robust Q1 growth with VYVGART expansion - Investing.com
Investing.com
argenx shares rise as Stifel raises price target to $485 - Investing.com
Investing.com
argenx ADR earnings missed by $0.29, revenue fell short of estimates - Investing.com India
Investing.com India
argenx ADR earnings missed by $0.29, revenue fell short of estimates - Investing.com South Africa
Investing.com South Africa
argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Is a Surprise Coming for argenx (ARGX) This Earnings Season?
Zacks Investment Research
argenx announces results of Annual General Meeting of Shareholders
GlobeNewswire Inc.
Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
Zacks Investment Research
argenx to Present at BofA Securities 2024 Health Care Conference
GlobeNewswire Inc.
Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
Zacks Investment Research
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks Investment Research
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
GlobeNewswire Inc.
Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
Perrigo (PRGO) to Report Q1 Earnings: Here's What to Expect
Zacks Investment Research
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks Investment Research
What's in Store for ADMA Biologics (ADMA) in Q1 Earnings?
Zacks Investment Research
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
Zacks Investment Research
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks Investment Research
Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
The Analyst Verdict: argenx In The Eyes Of 12 Experts
Benzinga
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
GlobeNewswire Inc.
Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
Benzinga
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
GlobeNewswire Inc.
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
GlobeNewswire Inc.
Key Takeaways From argenx Analyst Ratings
Benzinga
Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
GlobeNewswire Inc.
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
Zacks Investment Research
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
Zacks Investment Research
Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday - Zacks Investment Research
Zacks Investment Research
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Guess? Posts Upbeat Earnings, Joins Lufax, Nortech Systems And Other Big Stocks Moving Higher On Thursday
Benzinga
Why Micron Therapies Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga
Weekly Upgrades and Downgrades - InvestorPlace
InvestorPlace
argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
GlobeNewswire Inc.
Truist raises Argenx target to $440 on CIDP, Sjogren's treatment prospects - Investing.com India
Investing.com India
argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire Inc.
Is a Surprise Coming for argenx (ARGX) This Earnings Season?
Zacks Investment Research
argenx to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
ARGX Stock Quote Price and Forecast - CNN
CNN
Can Rising Operating Costs Affect Acadia's (ACHC) Q4 Earnings?
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):